Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Identification of a C-terminal cdc25 sequence required for promotion of germinal vesicle breakdown.
Powers EA
,
Thompson DP
,
Garner-Hamrick PA
,
He W
,
Yem AW
,
Bannow CA
,
Staples DJ
,
Waszak GA
,
Smith CW
,
Deibel MR
,
Fisher C
.
???displayArticle.abstract???
Glutathione S-transferase (GST)-cdc25B(31-566) induced germinal vesicle breakdown (GVBD) when microinjected into Xenopus oocytes. Purified, N-terminally truncated forms of cdc25B did not induce GVBD, even though many had phosphatase activity and activated cdc2 in vitro. N-terminally truncated forms of cdc25B inhibited induction of GVBD by longer forms of the enzyme suggesting a direct interaction in vivo. cdc25B(356-556), but not cdc25B(364-529), inhibited GVBD induction by GST-cdc25B(31-566) suggesting that a region of cdc25B near to the C-terminus was responsible for the inhibition. To determine the region of peptide sequence that was inhibitory, cdc25B(356-556) was subjected to proteolysis with endoproteinase lys-C. Following a demonstration that the resulting peptide mixture inhibited GST-cdc25B-dependent GVBD, a series of peptides spanning amino acids at the C-terminus were synthesized. The peptide TRSWAGERSR inhibited GVBD induced by GST-cdc25B. An alanine scan of the peptide revealed residues critical for GVBD inhibition, and site-directed mutagenesis of the corresponding residues in GST-cdc25B(31-566) eliminated its ability to induce GVBD. These results demonstrate that a cdc25B C-terminal domain, involved in dominant-negative inhibition of GVBD-competent cdc25B, is required for induction of GVBD following microinjection into oocytes.
Abeliovich,
Reversible oxidative aggregation obstructs specific proteolytic cleavage of glutathione S-transferase fusion proteins.
1995, Pubmed
Abeliovich,
Reversible oxidative aggregation obstructs specific proteolytic cleavage of glutathione S-transferase fusion proteins.
1995,
Pubmed
Abrieu,
The Polo-like kinase Plx1 is a component of the MPF amplification loop at the G2/M-phase transition of the cell cycle in Xenopus eggs.
1998,
Pubmed
,
Xenbase
Alewood,
Rapid in situ neutralization protocols for Boc and Fmoc solid-phase chemistries.
1997,
Pubmed
Baldin,
Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control?
1997,
Pubmed
Blasina,
A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase.
1999,
Pubmed
Bradford,
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
1976,
Pubmed
Cans,
Proteasome-dependent degradation of human CDC25B phosphatase.
1999,
Pubmed
Conklin,
14-3-3 proteins associate with cdc25 phosphatases.
1995,
Pubmed
Crenshaw,
The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1.
1998,
Pubmed
,
Xenbase
Cyert,
Regulation of MPF activity in vitro.
1988,
Pubmed
,
Xenbase
Draetta,
Cdc25 protein phosphatases in cell proliferation.
1997,
Pubmed
Duchesne,
Identification of the SH3 domain of GAP as an essential sequence for Ras-GAP-mediated signaling.
1993,
Pubmed
,
Xenbase
Dunphy,
Fission yeast p13 blocks mitotic activation and tyrosine dephosphorylation of the Xenopus cdc2 protein kinase.
1989,
Pubmed
,
Xenbase
Dunphy,
The cdc25 protein contains an intrinsic phosphatase activity.
1991,
Pubmed
Fattaey,
Myt1: a Wee1-type kinase that phosphorylates Cdc2 on residue Thr14.
1997,
Pubmed
Fauman,
Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A.
1998,
Pubmed
Furnari,
Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase.
1997,
Pubmed
Galaktionov,
Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins.
1991,
Pubmed
Galaktionov,
Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation.
1995,
Pubmed
,
Xenbase
Garner-Hamrick,
Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent antiproliferative effects.
1998,
Pubmed
Gautier,
cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2.
1991,
Pubmed
,
Xenbase
Hoffmann,
Phosphorylation and activation of human cdc25-C by cdc2--cyclin B and its involvement in the self-amplification of MPF at mitosis.
1993,
Pubmed
,
Xenbase
Hoffmann,
Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.
1994,
Pubmed
Horiguchi,
Dnacin A1 and dnacin B1 are antitumor antibiotics that inhibit cdc25B phosphatase activity.
1994,
Pubmed
Izumi,
Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase.
1993,
Pubmed
,
Xenbase
Jinno,
Cdc25A is a novel phosphatase functioning early in the cell cycle.
1994,
Pubmed
Kakizuka,
A mouse cdc25 homolog is differentially and developmentally expressed.
1992,
Pubmed
Kaldis,
Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities.
1998,
Pubmed
Karaïskou,
MPF amplification in Xenopus oocyte extracts depends on a two-step activation of cdc25 phosphatase.
1998,
Pubmed
,
Xenbase
Kim,
A maternal form of the phosphatase Cdc25A regulates early embryonic cell cycles in Xenopus laevis.
1999,
Pubmed
,
Xenbase
Kumagai,
Purification and molecular cloning of Plx1, a Cdc25-regulatory kinase from Xenopus egg extracts.
1996,
Pubmed
,
Xenbase
Laemmli,
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
1970,
Pubmed
Lammer,
The cdc25B phosphatase is essential for the G2/M phase transition in human cells.
1998,
Pubmed
Lee,
cdc25+ encodes a protein phosphatase that dephosphorylates p34cdc2.
1992,
Pubmed
,
Xenbase
Lopez-Girona,
Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein.
1999,
Pubmed
Losardo,
Ras-dependent maturation of Xenopus oocytes is blocked by modified peptides of GTPase activating protein (GAP).
1995,
Pubmed
,
Xenbase
Lu,
Function of WW domains as phosphoserine- or phosphothreonine-binding modules.
1999,
Pubmed
Morgan,
Principles of CDK regulation.
1995,
Pubmed
Nagata,
An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells.
1991,
Pubmed
Nishijima,
A dual-specificity phosphatase Cdc25B is an unstable protein and triggers p34(cdc2)/cyclin B activation in hamster BHK21 cells arrested with hydroxyurea.
1997,
Pubmed
Okazaki,
Isolation of a cDNA encoding the X enopus homologue of mammalian Cdc25A that can induce meiotic maturation of oocytes.
1996,
Pubmed
,
Xenbase
Peng,
Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.
1997,
Pubmed
Reynolds,
Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle.
1999,
Pubmed
Sadhu,
Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2.
1990,
Pubmed
Sanchez,
Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.
1997,
Pubmed
Shen,
The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins.
1998,
Pubmed
,
Xenbase
Zeng,
Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1.
1998,
Pubmed
Zeng,
DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding.
1999,
Pubmed
Zheng,
Functional analysis of the P box, a domain in cyclin B required for the activation of Cdc25.
1993,
Pubmed
,
Xenbase
